Dr. Tucker uses a new outpatient procedure called Lapiplasty 3D Bunion Correction, which realigns and secures the unstable joint with titanium plates at mid-foot (where the toe bone actually begins).

YOUR HEALTH: Breakthrough bunion procedure The API failed to deliver the resource. Now, a new procedure is offering hope to get rid of bunions once and for all.

Studies show up to 99 percent of patients do not have a recurrence of the bunion 17 months after the surgery. Lapiplasty 3D bunion correction is generally covered by most insurances and Medicare.

Paul proudly says, “It’s about getting back to what I truly love doing.” The Lapiplasty procedure has also shown a low recurrence rate. Studies show up to 99 percent of patients do not have a ...

Studies show up to 99 percent of patients do not have a recurrence of the bunion 17 months after the surgery. Lapiplasty 3D bunion correction is generally covered by most insurances and Medicare.

Treace Medical Concepts announces limited release of Percuplasty™ system for 3D bunion correction, enhancing minimally invasive surgery options.

West Morris Surgery Center in Ledgewood, N.J., performed its first bunion surgery using Treace Medical Concept's Lapiplasty procedure, the ASC said Dec. 20.

Advancement in bunion surgery A relatively new form of bunion surgery called Lapiplasty 3D Bunion Correction was cleared by the FDA in 2016.

Treace Medical (TMCI) Concepts announced the limited market release of the Nanoplasty 3D Minimally Invasive, MIS, Bunion Correction System and Procedure, a revolutionary approach to minimally ...

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure ...

Voom™ Medical Devices, Inc. (Voom™ Medical Devices’ Bunionplasty® 360 Bunion Repair™ Solution Offers Modern Alternative to Traditional 3D Approaches ...

Now, Carrasquillo is using a new FDA-cleared Lapiplasty 3D bunion correction procedure to get to the root of the problem. “It’s three dimensional.